SlideShare a Scribd company logo
2
Most read
3
Most read
14
Most read
Jinu Janet Varghese
Parasseril Margrace David
Joyson
Group: 4, Year: 6
Introduction
• MDMA (3,4-methylenedioxy-methamphetamine), popularly known as
ecstasy or, more recently, as Molly, is a synthetic, psychoactive drug
that has similarities to both the stimulant amphetamine and the
hallucinogen mescaline.
• an illegal drug that acts as both a stimulant and psychedelic,
producing an energizing effect, as well as distortions in time and
perception and enhanced enjoyment from tactile experiences.
Physical & chemical properties
• The free base of MDMA is a colorless oil that is insoluble in water. The
most common salt of MDMA is the hydrochloride salt; pure MDMA
hydrochloride is water soluble and appears as a white or off-white
powder or crystal.
History
• MDMA was first synthesized by a German company in 1912, possibly
to be used as an appetite suppressant. MDMA has been available as a
street drug since the 1980s. Its use escalated in the 1990s among
college students and young adults. It is most often distributed at late-
night parties called "raves", nightclubs, and rock concerts. As the rave
and club scene expanded to metropolitan and suburban areas across
the country, MDMA use and distribution increased as well. MDMA is
frequently used in combination with other drugs. However, it is rarely
consumed with alcohol, as alcohol is believed to diminish its effects.
Statistics
• According to the National Institute on Drug Abuse (NIDA), Ecstasy use and
abuse has been rising in recent years, especially among middle school and
high school adolescents.
• In 2010, 7.3 percent of high school seniors reported using Ecstasy at least
once in their lives, as did 6.4 percent of 10th graders and 3.3 percent of
8th graders.
• In 2009, about 760,000 Americans over the age of 12 reported using
MDMA in the past month.
• About 5.7 percent of Americans over the age of 12, or 14.2 million people,
reported using MDMA or Ecstasy at least once in their lives.
• In 2009, about 1.1 million Americans said that they used Ecstasy for the
first time in the past year, a significant rise over the prior year when there
were 894,000 self-reporting first-time users.
Pharmacokinetics
• MDMA reaches maximal concentrations in the blood stream between
1.5 and 3 hr after ingestion. It is then slowly metabolized and
excreted, with levels of MDMA and its metabolites decreasing to half
their peak concentration over the next several hours. Sixty-five
percent of MDMA is excreted unchanged in the urine (in addition, 7%
is metabolized into MDA) during the 24 hours after ingestion. MDMA
is known to be metabolized by two main metabolic pathways: (1) O-
demethylenation followed by catechol-O-methyltransferase(COMT)-
catalyzed methylation and/or glucuronide/sulfate conjugation; and
(2) N-dealkylation, deamination, and oxidation to the
corresponding benzoic acid derivatives conjugated with glycine.
How Is MDMA Abused?
• MDMA is taken orally, usually as a capsule or tablet. The popular term
Molly (slang for “molecular”) refers to the pure crystalline powder
form of MDMA, usually sold in capsules. The drug’s effects last
approximately 3 to 6 hours, although it is not uncommon for users to
take a second dose of the drug as the effects of the first dose begin to
fade. It is commonly taken in combination with other drugs.
Effects on Brain
• MDMA acts by increasing the activity of three neurotransmitters,
serotonin, dopamine, and norepinephrine. The emotional and pro-
social effects of MDMA are likely caused directly or indirectly by the
release of large amounts of serotonin, which influences mood (as well
as other functions such as appetite and sleep). Serotonin also triggers
the re-lease of the hormones oxytocin and vasopressin, which play
important roles in love, trust, sexual arousal, and other social
experiences. This may account for the characteristic feelings of
emotional closeness and empathy produced by the drug
• The surge of serotonin caused by taking MDMA depletes the brain of
this important chemical, however, causing negative after effects—
including confusion, depression, sleep problems, drug craving, and
anxiety—that may occur soon after taking the drug or during the days
or even weeks thereafter.
• Some heavy MDMA users experience long-lasting confusion,
depression, sleep abnormalities, and problems with attention and
memory, although it is possible that some of these effects may be due
to the use of other drugs in combination with MDMA (especially
marijuana).
Overdose
Short term effects
• Impaired judgment
• False sense of affection
• Confusion
• Depression
• Sleep problems
• Severe anxiety
• Paranoia
• Drug cravings
• Muscle tension
• Faintness and chills or swelling
• Involuntary teeth clenching
• Blurred vision
• Nausea
Long term effects
• Long-lasting brain damage affecting thought and memory
• Damage to portions of the brain that regulate critical functions such
as learning, sleep and emotion
• Degenerated nerve branches and nerve endings
• Depression, anxiety, memory loss
• Kidney failure
• Hemorrhaging
• Psychosis
• Cardiovascular collapse
• Convulsions
• Death
Dependence and withdrawal
• Some studies indicate repeated recreational users of MDMA have
increased rates of depression and anxiety, even after quitting the
drug. Other meta analyses have reported possibility of impairment of
executive functioning. Approximately 60% of MDMA users
experience withdrawal symptoms, including, but not limited to:
fatigue, loss of appetite, depression, and trouble
concentrating. Tolerance is expected to occur with consistent MDMA
use.
Treatment
• There are no specific treatments for MDMA abuse. The most effective
treatments for drug abuse and addiction are cognitive behavioral
interventions that are designed to help modify the patient's thinking,
expectancies, and behaviors, and to increase skills in coping with life's
stressors. Drug abuse recovery support groups may be effective in
combination with behavioral interventions to support long-term,
drug-free recovery. There are currently no pharmacological
treatments for dependence on MDMA.
Ecstacy ppt

More Related Content

PPT
Mdma
PPTX
MDMA/Molly/Ecstasy Powerpoint
PPTX
Precursor chemicals
PPTX
Case Management Documentation - 7.22.16
KEY
Introduction to Psychedelic Chemistry: The Science Behind the Trip
PPTX
DRUG ADDICTION
PPTX
Researching with ChatGPT.pptx
PPT
Exame físico do Tórax
Mdma
MDMA/Molly/Ecstasy Powerpoint
Precursor chemicals
Case Management Documentation - 7.22.16
Introduction to Psychedelic Chemistry: The Science Behind the Trip
DRUG ADDICTION
Researching with ChatGPT.pptx
Exame físico do Tórax

What's hot (20)

PPTX
Ecstasy
PPT
E C S T A S Y
PPTX
Amphetamine toxicity slideshare
PPTX
PPTX
Alcohol poisoning
PPTX
Drug addiction a& dependence
PPT
Amphetamine.final.pptx
PPTX
Plant poisons
PPTX
Cannabis poisoning
PPTX
Dopamine
PPTX
stimulants
PPTX
DRUG INDUCED PSYCHOSIS 2.pptx
PPTX
Alzheimer’s disease
PPTX
Alcohol and alcoholism
PPT
Cocaine poisoning
PPTX
Drug dependence
PPTX
Presentation drugs
PDF
Basic Knowledge on MDMA
PPTX
Cannabis poisoning (Neurotic poison)
Ecstasy
E C S T A S Y
Amphetamine toxicity slideshare
Alcohol poisoning
Drug addiction a& dependence
Amphetamine.final.pptx
Plant poisons
Cannabis poisoning
Dopamine
stimulants
DRUG INDUCED PSYCHOSIS 2.pptx
Alzheimer’s disease
Alcohol and alcoholism
Cocaine poisoning
Drug dependence
Presentation drugs
Basic Knowledge on MDMA
Cannabis poisoning (Neurotic poison)
Ad

Viewers also liked (20)

PDF
Ecstasy presentation
PPTX
Ecstasy
PPTX
Ecstasy and its Affects Socially, Mentally, and Physically
PPTX
The dangerous effects of ecstasy
PPTX
Ecstasy and its Affects
PPT
Ecstasy
PPTX
PPTX
Infertility
PPT
PPTX
Marlon e joão
PPT
Ecstasy
PPTX
Bath salts presentation
PPTX
Tourette syndrome & other tic disorders
PPTX
Suspected appendicitis
PPT
Power point wctu spice - bath salts
PDF
Psychological features of women with gynecological pathology
DOCX
Informe .. (1)de kimik
PPTX
Gestational diabetes
Ecstasy presentation
Ecstasy
Ecstasy and its Affects Socially, Mentally, and Physically
The dangerous effects of ecstasy
Ecstasy and its Affects
Ecstasy
Infertility
Marlon e joão
Ecstasy
Bath salts presentation
Tourette syndrome & other tic disorders
Suspected appendicitis
Power point wctu spice - bath salts
Psychological features of women with gynecological pathology
Informe .. (1)de kimik
Gestational diabetes
Ad

Similar to Ecstacy ppt (20)

PPTX
Methamphetamine drug
PPTX
Anti-Depressant
PDF
Drug abuse
PPTX
Drug abuse
PPTX
Psychoactive drugs
PPTX
PDF
Ecstasy research paper
PDF
Ecstasy research paper
PPTX
Mdmafinal
PPTX
DRUGS- National Service Training Program Report.pptx
PDF
Drug abuse.pdflshglshglsjgsigjsi;ktgrdtgrter
DOC
Mdma (methylenedioxy methamphetamine) addiction hotline
PPTX
He 285 mdma teachback
PPTX
Toxicology assighnment.pptx The brain and reward system
PPTX
PPT
Illegal drugs
PPTX
addiction & substance use disorders.pptx
PPT
A final substance abuse assisting those with substance dependence 6 22-07
PPTX
Drug awareness
PPT
Drugs
Methamphetamine drug
Anti-Depressant
Drug abuse
Drug abuse
Psychoactive drugs
Ecstasy research paper
Ecstasy research paper
Mdmafinal
DRUGS- National Service Training Program Report.pptx
Drug abuse.pdflshglshglsjgsigjsi;ktgrdtgrter
Mdma (methylenedioxy methamphetamine) addiction hotline
He 285 mdma teachback
Toxicology assighnment.pptx The brain and reward system
Illegal drugs
addiction & substance use disorders.pptx
A final substance abuse assisting those with substance dependence 6 22-07
Drug awareness
Drugs

More from Tbilisi State Medical University (12)

PPTX
Hemolytic uremic syndrome
PPTX
First aid & emergency care of the injured
PPTX
PPTX
Brain cancer (tumors)
PPTX
Rickets in children
PPTX
Cutaneous tuberculosis
PPTX

Recently uploaded (20)

PDF
TISSUE LECTURE (anatomy and physiology )
PPTX
ONCOLOGY Principles of Radiotherapy.pptx
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPTX
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
PPTX
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PPTX
Reading between the Rings: Imaging in Brain Infections
PPT
Obstructive sleep apnea in orthodontics treatment
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPTX
Post Op complications in general surgery
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPT
HIV lecture final - student.pptfghjjkkejjhhge
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPTX
1. Basic chemist of Biomolecule (1).pptx
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
TISSUE LECTURE (anatomy and physiology )
ONCOLOGY Principles of Radiotherapy.pptx
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
PEADIATRICS NOTES.docx lecture notes for medical students
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
Reading between the Rings: Imaging in Brain Infections
Obstructive sleep apnea in orthodontics treatment
Rheumatology Member of Royal College of Physicians.ppt
Post Op complications in general surgery
nephrology MRCP - Member of Royal College of Physicians ppt
Electrolyte Disturbance in Paediatric - Nitthi.pptx
HIV lecture final - student.pptfghjjkkejjhhge
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
MENTAL HEALTH - NOTES.ppt for nursing students
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
1. Basic chemist of Biomolecule (1).pptx
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf

Ecstacy ppt

  • 1. Jinu Janet Varghese Parasseril Margrace David Joyson Group: 4, Year: 6
  • 2. Introduction • MDMA (3,4-methylenedioxy-methamphetamine), popularly known as ecstasy or, more recently, as Molly, is a synthetic, psychoactive drug that has similarities to both the stimulant amphetamine and the hallucinogen mescaline. • an illegal drug that acts as both a stimulant and psychedelic, producing an energizing effect, as well as distortions in time and perception and enhanced enjoyment from tactile experiences.
  • 3. Physical & chemical properties • The free base of MDMA is a colorless oil that is insoluble in water. The most common salt of MDMA is the hydrochloride salt; pure MDMA hydrochloride is water soluble and appears as a white or off-white powder or crystal.
  • 4. History • MDMA was first synthesized by a German company in 1912, possibly to be used as an appetite suppressant. MDMA has been available as a street drug since the 1980s. Its use escalated in the 1990s among college students and young adults. It is most often distributed at late- night parties called "raves", nightclubs, and rock concerts. As the rave and club scene expanded to metropolitan and suburban areas across the country, MDMA use and distribution increased as well. MDMA is frequently used in combination with other drugs. However, it is rarely consumed with alcohol, as alcohol is believed to diminish its effects.
  • 5. Statistics • According to the National Institute on Drug Abuse (NIDA), Ecstasy use and abuse has been rising in recent years, especially among middle school and high school adolescents. • In 2010, 7.3 percent of high school seniors reported using Ecstasy at least once in their lives, as did 6.4 percent of 10th graders and 3.3 percent of 8th graders. • In 2009, about 760,000 Americans over the age of 12 reported using MDMA in the past month. • About 5.7 percent of Americans over the age of 12, or 14.2 million people, reported using MDMA or Ecstasy at least once in their lives. • In 2009, about 1.1 million Americans said that they used Ecstasy for the first time in the past year, a significant rise over the prior year when there were 894,000 self-reporting first-time users.
  • 6. Pharmacokinetics • MDMA reaches maximal concentrations in the blood stream between 1.5 and 3 hr after ingestion. It is then slowly metabolized and excreted, with levels of MDMA and its metabolites decreasing to half their peak concentration over the next several hours. Sixty-five percent of MDMA is excreted unchanged in the urine (in addition, 7% is metabolized into MDA) during the 24 hours after ingestion. MDMA is known to be metabolized by two main metabolic pathways: (1) O- demethylenation followed by catechol-O-methyltransferase(COMT)- catalyzed methylation and/or glucuronide/sulfate conjugation; and (2) N-dealkylation, deamination, and oxidation to the corresponding benzoic acid derivatives conjugated with glycine.
  • 7. How Is MDMA Abused? • MDMA is taken orally, usually as a capsule or tablet. The popular term Molly (slang for “molecular”) refers to the pure crystalline powder form of MDMA, usually sold in capsules. The drug’s effects last approximately 3 to 6 hours, although it is not uncommon for users to take a second dose of the drug as the effects of the first dose begin to fade. It is commonly taken in combination with other drugs.
  • 8. Effects on Brain • MDMA acts by increasing the activity of three neurotransmitters, serotonin, dopamine, and norepinephrine. The emotional and pro- social effects of MDMA are likely caused directly or indirectly by the release of large amounts of serotonin, which influences mood (as well as other functions such as appetite and sleep). Serotonin also triggers the re-lease of the hormones oxytocin and vasopressin, which play important roles in love, trust, sexual arousal, and other social experiences. This may account for the characteristic feelings of emotional closeness and empathy produced by the drug
  • 9. • The surge of serotonin caused by taking MDMA depletes the brain of this important chemical, however, causing negative after effects— including confusion, depression, sleep problems, drug craving, and anxiety—that may occur soon after taking the drug or during the days or even weeks thereafter. • Some heavy MDMA users experience long-lasting confusion, depression, sleep abnormalities, and problems with attention and memory, although it is possible that some of these effects may be due to the use of other drugs in combination with MDMA (especially marijuana).
  • 11. Short term effects • Impaired judgment • False sense of affection • Confusion • Depression • Sleep problems • Severe anxiety • Paranoia • Drug cravings • Muscle tension • Faintness and chills or swelling • Involuntary teeth clenching • Blurred vision • Nausea
  • 12. Long term effects • Long-lasting brain damage affecting thought and memory • Damage to portions of the brain that regulate critical functions such as learning, sleep and emotion • Degenerated nerve branches and nerve endings • Depression, anxiety, memory loss • Kidney failure • Hemorrhaging • Psychosis • Cardiovascular collapse • Convulsions • Death
  • 13. Dependence and withdrawal • Some studies indicate repeated recreational users of MDMA have increased rates of depression and anxiety, even after quitting the drug. Other meta analyses have reported possibility of impairment of executive functioning. Approximately 60% of MDMA users experience withdrawal symptoms, including, but not limited to: fatigue, loss of appetite, depression, and trouble concentrating. Tolerance is expected to occur with consistent MDMA use.
  • 14. Treatment • There are no specific treatments for MDMA abuse. The most effective treatments for drug abuse and addiction are cognitive behavioral interventions that are designed to help modify the patient's thinking, expectancies, and behaviors, and to increase skills in coping with life's stressors. Drug abuse recovery support groups may be effective in combination with behavioral interventions to support long-term, drug-free recovery. There are currently no pharmacological treatments for dependence on MDMA.